Klett Theresa, Stahlecker Jason, Jaag Simon, Masberg Benedikt, Knappe Cornelius, Lämmerhofer Michael, Coles Murray, Stehle Thilo, Boeckler Frank M
Lab for Molecular Design & Pharm. Biophysics, Institute of Pharmaceutical Sciences, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
Pharmaceutical (Bio-)Analysis, Institute of Pharmaceutical Sciences, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
ACS Pharmacol Transl Sci. 2024 Nov 18;7(12):3984-3999. doi: 10.1021/acsptsci.4c00414. eCollection 2024 Dec 13.
The tumor suppressor p53 is frequently mutated in human cancers. The Y220C mutant is the ninth most common p53 cancer mutant and is classified as a structural mutant, as it leads to strong thermal destabilization and degradation by creating a solvent-accessible hydrophobic cleft. To identify small molecules that thermally stabilize p53, we employed DSF to screen SAr-type electrophiles from our covalent fragment library (CovLib) for binding to different structural (Y220C, R282W) and DNA contact (R273H) mutants of p53. The reactive fragments SN001, SN006, and SN007 were detected to specifically stabilize Y220C, indicating the arylation of Cys220 in the mutational cleft, as confirmed by X-ray crystallography. The fragments occupy the central cavity and mimic the ring system of the WT tyrosine lost by the mutation. Surpassing previously reported noncovalent ligands, SN001 stabilized T-p53C-Y220C concentration-dependently up to 4.45 °C and, due to its small size, represents a promising starting point for optimization.
肿瘤抑制因子p53在人类癌症中经常发生突变。Y220C突变体是p53癌症突变体中第九常见的类型,被归类为结构突变体,因为它通过产生一个溶剂可及的疏水裂缝导致强烈的热不稳定和降解。为了鉴定能热稳定p53的小分子,我们采用差示扫描荧光法(DSF)从我们的共价片段文库(CovLib)中筛选SAr型亲电试剂,以使其与p53的不同结构(Y220C、R282W)和DNA接触(R273H)突变体结合。检测到反应性片段SN001、SN006和SN007能特异性地稳定Y220C,这表明突变裂缝中的Cys220发生了芳基化,X射线晶体学证实了这一点。这些片段占据中心腔并模拟因突变而缺失的野生型酪氨酸的环系统。超过先前报道的非共价配体,SN001浓度依赖性地将T-p53C-Y220C稳定高达4.45℃,并且由于其尺寸小,代表了一个有前景的优化起点。